Jeffrey W. Dunn Sells 1,609 Shares of SI-BONE, Inc. Stock

SIBN Stock  USD 16.39  0.01  0.06%   
About 55% of Si Bone's investors are presently thinking to get in. The analysis of overall sentiment of trading Si Bone stock suggests that some investors are interested at this time. Si Bone's investing sentiment overview a quick insight into current market opportunities from investing in Si Bone. Many technical investors use Si Bone stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
SI-BONE, Inc. Director Jeffrey W. Dunn sold 1,609 shares of the businesss stock in a transaction on Monday, November 18th. The stock was sold at an average price of 12.43, for a total transaction of 19,999.87. Following the completion of the sale, the director now directly owns 20,431 shares in

Read at thelincolnianonline.com
news
  

Si Bone Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Si Bone can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Si Bone Maximum Pain Price Across April 17th 2025 Option Contracts

Si Bone's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Si Bone close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Si Bone's options.

Si Bone Fundamental Analysis

We analyze Si Bone's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Si Bone using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Si Bone based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Working Capital

Working Capital Comparative Analysis

Si Bone is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Si Bone Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Si Bone stock to make a market-neutral strategy. Peer analysis of Si Bone could also be used in its relative valuation, which is a method of valuing Si Bone by comparing valuation metrics with similar companies.

Peers

Si Bone Related Equities

SGHTSight Sciences   7.03   
0%
100.0%
TMCITreace Medical   2.65   
0%
37.0%
TCMDTactile Systems   2.30   
0%
32.0%
NPCENeuropace   1.82   
0%
25.0%
ITGRInteger Holdings   1.68   
0%
23.0%
OFIXOrthofix Medical   1.58   
0%
22.0%
ESTAEstablishment Labs   0.00   
0%
0%
AXGNAxogen   0.06   
1.0%
0%
IRMDIradimed   0.32   
4.0%
0%
KIDSOrthopediatrics Corp   1.76   
25.0%
0%
CNMDCONMED   1.90   
27.0%
0%
RPIDRapid Micro   2.52   
35.0%
0%
LUNGPulmonx Corp   5.56   
79.0%
0%
RXSTRxsight   6.46   
91.0%
0%
When determining whether Si Bone offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Si Bone's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Si Bone Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Si Bone Stock:
Check out Si Bone Hype Analysis, Si Bone Correlation and Si Bone Performance.
To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Si Bone. If investors know SIBN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Si Bone listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.91)
Revenue Per Share
3.817
Quarterly Revenue Growth
0.186
Return On Assets
(0.12)
Return On Equity
(0.22)
The market value of Si Bone is measured differently than its book value, which is the value of SIBN that is recorded on the company's balance sheet. Investors also form their own opinion of Si Bone's value that differs from its market value or its book value, called intrinsic value, which is Si Bone's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Si Bone's market value can be influenced by many factors that don't directly affect Si Bone's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Si Bone's value and its price as these two are different measures arrived at by different means. Investors typically determine if Si Bone is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Si Bone's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.